In this article, learn about:
The FDA rulebooks that govern cosmetic and OTC drug labels
What dual-labeled products must include to satisfy both
How labeling errors turn into retailer chargebacks
Under the FDA, cosmetics and OTC drugs are not two flavors of the same labeling rulebook. They're two separate regimes, built for different purposes, with different required elements, different formatting rules, and different consequences for getting them wrong.
A cosmetic label is beholden to the Fair Packaging and Labeling Act (FPLA) and the FDA's cosmetic labeling regulations. An OTC drug label, on the other hand, answers to a standardized Drug Facts panel, with fixed headings in a fixed order that leave no room for interpretation. Products that qualify as both, such as an anti-dandruff shampoo or an SPF moisturizer, have to satisfy both rulebooks on the same piece of packaging.
This article walks through what each regime requires, how dual-classified products carry both label types at once, and why the product data that has to be right on the label is also the same data suppliers submit to retailers.
Why Product Classification Determines the Label
Classification comes first because it decides which set of legal requirements applies. Everything about the label follows from that one decision.
Here's the mechanism: FDA decides whether a product is a cosmetic or a drug based on intended use, meaning the claims made for it, not its ingredients or how a supplier thinks of it internally. For instance, a lotion with no medical claim is a cosmetic, while the same lotion labeled "treats eczema" is now a drug, because that claim asserts a therapeutic effect on the body.
Each statute (the Fair Packaging and Labeling Act for cosmetics and the Federal Food, Drug, and Cosmetic Act for OTC drugs) specifies its own required label elements. If the classification is cosmetic, an ingredient declaration and identity statement are legally sufficient. No Drug Facts panel is required. But if a claim tips the product into drug territory, that same package is now missing a legally mandated panel, regardless of how accurate or well-formatted the rest of the label is.
What a Cosmetic Label Must Include
Cosmetic labeling is governed by the Fair Packaging and Labeling Act and the FDA's cosmetic labeling regulations under 21 CFR Part 701, a separate framework from OTC drugs.
A compliant cosmetic label includes:
Identity statement: What the product is, stated in plain terms, on the front of the package (the principal display panel).
Net quantity of contents: Weight or volume, with specific rules governing placement, type size, and how it's expressed relative to the rest of the panel.
Name and place of business: The manufacturer, packer, or distributor, identified clearly enough that the responsible party is traceable.
Ingredient declaration: Every ingredient listed in descending order of predominance, using INCI naming conventions so ingredient names are standardized across products and brands.
Warning statements, where applicable: Required for certain product types (aerosols, for example) or triggered by specific ingredients that carry FDA-mandated cautionary language.
What ties these elements together is that every one of them is a factual claim the FDA can check against the product itself. There's no discretion in any of it, which means there's no margin for a label that's close enough. A cosmetic label is a set of specific, checkable facts, and getting any one of them wrong can result in costly compliance issues.
What an OTC Drug Label Must Include
OTC drug labeling is governed by 21 CFR 201.66, which specifies a standardized Drug Facts panel. The Drug Facts panel includes, in this order:
Active ingredient(s) and purpose: Each active ingredient listed with what it's meant to do.
Uses: The specific symptoms or conditions the product is intended to treat or prevent.
Warnings: Required cautionary information, including when to stop use and when to consult a doctor.
Directions: How to use the product, including dose, frequency, and any age-based instructions.
Other information: Storage requirements and any additional facts not covered elsewhere.
Inactive ingredients: Must be listed separately from active ingredients.
Questions or comments, if applicable: Contact information for consumers who need more detail.
Order matters. A Drug Facts panel with every required fact but the wrong sequence is still out of compliance.
Beyond the panel itself, several other requirements are just as mandatory:
Alphabetical active ingredients (combination products): In products like SPF moisturizers, drug ingredients are listed alphabetically under "Active Ingredients," with the cosmetic ingredients listed separately in descending order of predominance as "Inactive Ingredients."
Expiration date. Required on the container for all OTC drug products and must be backed by stability testing data, not an estimate.
Tamper-evident statement. Most OTC packages must identify the specific tamper-evident feature used, placed prominently enough that it stays visible even if the feature is breached.
Child-resistant packaging labels. Under the Poison Prevention Packaging Act, any package sold in a non-child-resistant size must carry a specific warning that it isn't intended for households with children.
"Keep out of reach of children." A specific statement FDA looks for as a standard feature of drug safety labeling, distinct from the general warnings language in the panel.
Dual-Labeled Products
Some cosmetic products include drug ingredients, such as anti-dandruff shampoos with pyrithione zinc, SPF moisturizers, antiperspirants, and acne washes. Each combines a monograph OTC active ingredient with a product that also makes ordinary cosmetic claims, like softening skin or adding fragrance.
That dual function means the label has to satisfy both regimes simultaneously, on the same package. A compliant Drug Facts panel doesn't excuse a supplier from the cosmetic identity statement, and a well-formatted cosmetic label doesn't excuse them from the Drug Facts panel. Both requirements apply in full, because the product is legally both things at once.
The most common failure point shows up in the ingredients themselves. Suppliers list the active ingredients correctly under the Drug Facts panel, then treat the "Inactive Ingredients" line underneath it as if that satisfies the cosmetic ingredient declaration requirement. However, it doesn't. The two lists don't fully overlap in format or in ordering expectations. Treating one as a stand-in for the other is exactly the kind of gap that turns into a compliance issue down the road.
The other friction comes from the labels themselves. Both panels come with their own placement and type-size rules, and a small bottle or tube only has so much surface area. Fitting a Drug Facts panel and a full cosmetic ingredient declaration onto one package, without shrinking either one below its required minimums or crowding out the identity statement, is a genuine layout problem, and it's one suppliers have to solve before the product ever ships.
Where Labeling Data Becomes Retailer Data
The same four data points the FDA requires on the physical label (identity, net contents, ingredient list, and product identifiers) are the same attributes retailers require in item setup: GS1 attributes, GTIN, product descriptions, and package dimensions. Both systems are describing the same physical product, and they're pulling from the same source data a supplier maintains internally.
This means that an error doesn’t stay contained to the label. If the net quantity is wrong on the package, it's very likely wrong in the item data a supplier submitted to the retailer too, because both came from the same internal record. A carton that arrives with a different net quantity than what's on file triggers a receiving discrepancy, and a receiving discrepancy triggers a chargeback, a rejected shipment, or a scorecard ding, regardless of whether the supplier's labeling error was minor.
On one side, there's FDA misbranding exposure for the label itself. On the other, there's the retailer compliance penalty for the same underlying error, now showing up as a business problem instead of a regulatory issue. Suppliers who treat product data as one accurate source, verified once and used everywhere it's needed, avoid paying for the same mistake twice. Suppliers who treat the label and the retailer item data as two separate tasks are the ones who find out the hard way that they were never actually separate.
Related Reading: Packaging Guide for Retail Suppliers
Practical Steps for Staying Compliant With Both Cosmetic and OTC Drug Regulations
Getting a label right means staying compliant across every SKU, every reformulation, and every retailer. Here's how to put that discipline to work:
Confirm classification before finalizing the label. Every downstream requirement flows from this decision, so revisit it any time a claim changes, not just at the initial launch.
Build ingredient declarations once, from a single verified source. Use that same source for the physical label and the retailer item data submission, rather than maintaining two versions that can drift apart.
Route Drug Facts panel content through regulatory review. The panel's format and content are non-negotiable in a way the rest of the packaging isn't.
Audit label data against retailer item data at launch and after any reformulation. A formula change that alters net contents or an ingredient order should trigger a check on both sides, not just the label.
Watch for state-level add-ons that layer onto federal requirements, like California's Prop 65 warning requirements, which apply independently of FPLA or Drug Facts obligations.
Maintain cosmetic safety substantiation records. Under the Modernization of Cosmetics Regulation Act (MoCRA), brands are required to keep records substantiating the safety of each cosmetic product. Without them, a product can be deemedadulterated regardless of how accurate the label is.
Keep facility registrations and product listings current. Manufacturing facilities generally require registration renewal on a set cycle, and marketed products, including full ingredient lists, need to be listed with FDA through the Cosmetics Direct portal.
Support expiration dates with real stability data. For OTC drugs, expiration dates need to be backed by real-time and accelerated stability testing, not an industry-standard estimate applied by default.
Verify tamper-evident and child-resistant packaging where required. OTC drugs generally need a tamper-evident feature with a descriptive label statement. Certain cosmetics, like low-viscosity baby oils, carry their own child-resistant packaging requirements under the PPPA.
Check bilingual requirements for cross-border shipments. Product sold into Canada, for example, generally needs mandatory label information, including warnings, directions, and ingredients, in both English and French.
Keep lot and batch traceability current. A logistics system that can trace lot codes is what makes a recall workable if the FDA or a retailer requires a product withdrawal.
Getting Product Data Right the First Time
The label is one output of accurate product data. The item information a retailer requires is another. SPS Assortment centralizes, validates, and distributes accurate product data to the right channels and partners, so the identity, ingredients, and net contents a supplier verifies once don't have to be re-entered or reconciled separately for every retailer.
Assortment is built as a comprehensive solution for complete and accurate product information across all channels, which is exactly the gap that turns a labeling error into a retailer chargeback in the first place. Contact SPS Commerce to see how Assortment fits into your product data process.